» Articles » PMID: 17267381

Spike Protein of SARS-CoV Stimulates Cyclooxygenase-2 Expression Via Both Calcium-dependent and Calcium-independent Protein Kinase C Pathways

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2007 Feb 3
PMID 17267381
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that the nucleocapsid protein of SARS-associated coronavirus (SARS-CoV) activated cyclooxygenase-2 (COX-2) expression. In this study, we identified another viral protein, the spike of SARS-CoV, which played an important role in virus-stimulated COX-2 expression after screening all genes from the SARS-CoV genome. We found that an upstream calcium-dependent PKC isozyme PKC alpha that modulates the downstream ERK/NF-kappaB pathway through an influx of extracellular Ca2+ is induced by the spike protein of SARS-CoV. The ERK/NF-kappaB was identified to be involved in the activation of COX-2 promoter and production of COX-2 protein in HEK293T cells. We also demonstrated that another unusual pathway, the calcium-independent PI3K/PKC epsilon/JNK/CREB pathway, functioned in cooperation with the calcium-dependent pathway to induce COX-2 expression upon stimulation by spike protein. This pathway can be blocked by PKC epsilon-specific, small interfering RNA, PI3K/JNK kinase-specific inhibitors as well as dominant negative JNK. PKC epsilon-specific siRNA also attenuated the phosphorylation of JNK. Our results provide evidence that helps us understand the function of SRAS-CoV spike protein in SARS pathogenesis.

Citing Articles

Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression.

Tramontozzi C, Riccio A, Pauciullo S, La Frazia S, Rossi A, Santoro M J Virus Erad. 2024; 10(3):100387.

PMID: 39399815 PMC: 11470169. DOI: 10.1016/j.jve.2024.100387.


Repurposing Anticancer Drugs Targeting the MAPK/ERK Signaling Pathway for the Treatment of Respiratory Virus Infections.

Liu Y, Luo Z Int J Mol Sci. 2024; 25(13).

PMID: 39000055 PMC: 11240997. DOI: 10.3390/ijms25136946.


Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies.

Moshawih S, Jarrar Q, Bahrin A, Lim A, Ming L, Goh H Heliyon. 2024; 10(3):e25734.

PMID: 38356603 PMC: 10864964. DOI: 10.1016/j.heliyon.2024.e25734.


Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective.

Karousis E, Schubert K, Ban N EMBO J. 2024; 43(2):151-167.

PMID: 38200146 PMC: 10897431. DOI: 10.1038/s44318-023-00019-8.


S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review.

Nejat R, Torshizi M, Najafi D Vaccines (Basel). 2023; 11(2).

PMID: 36851081 PMC: 9968219. DOI: 10.3390/vaccines11020204.